(a)The controlled substances listed in this section are included in Schedule II.
(b)Any of the following substances, except those narcotic drugs listed in other schedules, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by combination of extraction and chemical synthesis:
(1)Opium, opiate, and any salt, compound, derivative, or preparation of opium or opiate, with the exception of naloxone hydrochloride (N-allyl-14-hydroxy-nordihydromorphinone hydrochloride), but including the following:
(H)Ethylmorphine.
(I)
(ii)Hydrocodone combination p
Free access — add to your briefcase to read the full text and ask questions with AI
(a)
The controlled substances listed in this section are included in Schedule II.
(b)
Any of the following substances, except those narcotic drugs listed in other schedules, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by combination of extraction and chemical synthesis:
(1)
Opium, opiate, and any salt, compound, derivative, or preparation of opium or opiate, with the exception of naloxone hydrochloride (N-allyl-14-hydroxy-nordihydromorphinone hydrochloride), but including the following:
(A)
Raw opium.
(B)
Opium extracts.
(C)
Opium fluid extracts.
(D)
Powdered opium.
(E)
Granulated opium.
(F)
Tincture of opium.
(G)
Codeine.
(H)
Ethylmorphine.
(I)
(i)
Hydrocodone.
(ii)
Hydrocodone combination products with not more than 300
milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts.
(iii)
Oral liquid preparations of dihydrocodeinone containing the above specified amounts that contain, as its nonnarcotic ingredients, two or more antihistamines in combination with each other.
(iv)
Hydrocodone combination products with not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium.
(J)
Hydromorphone.
(K)
Metopon.
(L)
Morphine.
(M)
Oxycodone.
(N)
Oxymorphone.
(O)
Thebaine.
(2)
Any salt, compound, isomer, or derivative, whether natural or synthetic, of the substances referred to in paragraph (1), but not including the isoquinoline alkaloids of opium.
(3)
Opium poppy and poppy straw.
(4)
Coca leaves and any salt, compound, derivative, or preparation of coca leaves, but not including decocainized coca leaves or extractions which do not contain cocaine or ecgonine.
(5)
Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid, or powder form which contains the
phenanthrene alkaloids of the opium poppy).
(6)
Cocaine, except as specified in Section 11054.
(7)
Ecgonine, whether natural or synthetic, or any salt, isomer, derivative, or preparation thereof.
(c)
Opiates. Unless specifically excepted or unless in another schedule, any of the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of those isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan and levopropoxyphene excepted:
(1)
Alfentanyl.
(2)
Alphaprodine.
(3)
Anileridine.
(4)
Bezitramide.
(5)
Bulk dextropropoxyphene (nondosage forms).
(6)
Dihydrocodeine.
(7)
Diphenoxylate.
(8)
Fentanyl.
(9)
Isomethadone.
(10)
Levoalphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM. This substance is authorized for the treatment of narcotic addicts under federal law (see Part 291 (commencing with Section 291.501) and Part 1308
(commencing with Section 1308.01) of Title 21 of the Code of Federal Regulations).
(11)
Levomethorphan.
(12)
Levorphanol.
(13)
Metazocine.
(14)
Methadone.
(15)
Methadone-Intermediate, 4-cyano-2-dimethylamino-4,
4-diphenyl butane.
(16)
Moramide-Intermediate, 2-methyl-3-morpholino-1,
1-diphenylpropane-carboxylic acid.
(17)
Pethidine (meperidine).
(18)
Pethidine-Intermediate-A,
4-cyano-1-methyl-4-phenylpiperidine.
(19)
Pethidine-Intermediate-B,
ethyl-4-phenylpiperidine-4-carboxylate.
(20)
Pethidine-Intermediate-C,
1-methyl-4-phenylpiperidine-4-carboxylic acid.
(21)
Phenazocine.
(22)
Piminodine.
(23)
Racemethorphan.
(24)
Racemorphan.
(25)
Sufentanyl.
(d)
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of
the following substances having a stimulant effect on the central nervous system:
(1)
Amphetamine, its salts, optical isomers, and salts of its optical isomers.
(2)
Methamphetamine, its salts, isomers, and salts of its isomers.
(3)
Dimethylamphetamine (N,N-dimethylamphetamine), its salts, isomers, and salts of its isomers.
(4)
N-Ethylmethamphetamine (N-ethyl, N-methylamphetamine), its salts, isomers, and salts of its isomers.
(5)
Phenmetrazine and its salts.
(6)
Methylphenidate.
(7)
Khat, which includes all parts of the plant classified botanically as Catha Edulis, whether growing or not, the seeds thereof, any extract from any part of the plant, and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or extracts.
(8)
Cathinone (also known as alpha-aminopropiophenone,
2-aminopropiophenone, and norephedrone).
(e)
Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of those salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1)
Amobarbital.
(2)
Pentobarbital.
(3)
Phencyclidines, including the following:
(A)
1-(1-phenylcyclohexyl) piperidine (PCP).
(B)
1-(1-phenylcyclohexyl) morpholine (PCM).
(C)
Any analog of phencyclidine which is added by the Attorney General by regulation pursuant to this paragraph.
The Attorney General, or his or her designee, may, by rule or regulation, add additional analogs of phencyclidine to those enumerated in this paragraph after notice, posting, and hearing pursuant to Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. The Attorney General shall, in the calendar year of the regular session of the Legislature in which the rule or regulation is adopted, submit a draft of a proposed bill to each house of the Legislature which would incorporate the analogs into this code. No rule or regulation shall remain in
effect beyond January 1 after the calendar year of the regular session in which the draft of the proposed bill is submitted to each house. However, if the draft of the proposed bill is submitted during a recess of the Legislature exceeding 45 calendar days, the rule or regulation shall be effective until January 1 after the next calendar year.
(4)
Secobarbital.
(5)
Glutethimide.
(f)
Immediate precursors. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:
(1)
Immediate precursor to amphetamine and methamphetamine:
(A)
Phenylacetone. Some trade or other names: phenyl-2 propanone; P2P; benzyl methyl ketone; methyl benzyl ketone.
(2)
Immediate precursors to phencyclidine (PCP):
(A)
1-phenylcyclohexylamine.
(B)
1-piperidinocyclohexane carbonitrile (PCC).